Registro de síndrome coronariana aguda em um centro de emergências em cardiologia Acute coronary syndrome registry at a cardiology emergency center

Autor: Elizabete Silva dos Santos, Luiz Minuzzo, Marcos Paulo Pereira, Maria Teresa Cabrera Castillo, Manoel Ângelo Gomes Palácio, Rui Fernando Ramos, Ari Timerman, Leopoldo Soares Piegas
Jazyk: English<br />Portuguese
Rok vydání: 2006
Předmět:
Zdroj: Arquivos Brasileiros de Cardiologia, Vol 87, Iss 5, Pp 597-602 (2006)
Druh dokumentu: article
ISSN: 0066-782X
1678-4170
DOI: 10.1590/S0066-782X2006001800008
Popis: OBJETIVO: Descrever as características de pacientes (P) com suspeita clínica de síndrome coronariana aguda (SCA), identificando-se o tratamento médico e a mortalidade hospitalar. MÉTODOS: Avaliamos 860 pacientes com SCA de janeiro a dezembro de 2003. Analisamos características basais, modalidade de apresentação da SCA, medicamentos durante a internação, indicação de tratamento clínico ou de revascularização miocárdica (RM) e mortalidade hospitalar. RESULTADOS: Foram 503 (58,3%) pacientes do sexo masculino, com média de idade de 62,6 anos (±11,9). O diagnóstico na alta hospitalar foi de infarto agudo do miocárdio (IAM) com supradesnivelamento do segmento ST (SST) em 78 (9,1%), IAM sem SST em 238 (27,7%), angina instável (AI) em 516 (60%), manifestação atípica da SCA (síncope ou dispnéia) em dois (0,2%) e dor torácica não cardíaca em 26 (3%). Foram medicados com betabloqueador em 87,9%, AAS em 95,9%, anti-trombínico em 89,9%, nitroglicerina EV em 86,2%, inibidor do receptor de glicoproteína (IGP) IIb/IIIa em 6,4%, clopidogrel em 35,9%, inibidor da enzima conversora da angiotensina (IECA) em 77,9% e estatina em 70,9%. A cinecoronariografia foi realizada em 72 pacientes (92,3%) com IAM com SST e em 452 (59,8%) com SCA sem SST (pOBJECTIVE: Describe clinical characteristics of patients (P) admitted to hospital with suspected acute coronary syndrome (ACS), identifying medical treatment and in-hospital mortality. METHODS: Evaluated were 860 patients with ACS from January through December, 2003. We evaluated baseline characteristics, ACS mode of presentation, medication during hospital stay, indication for clinical treatment or myocardial revascularization (MR) and in-hospital mortality. RESULTS: Five hundred and three (58.3%) were male, mean age 62.6 years (± 11.9). Seventy-eight (9.1%) were discharged with the diagnosis of acute ST-elevation myocardial infarction (STEMI), 238 (27.7%) with non-ST-elevation myocardial infarction (non-STEMI), 516 (60%) with unstable angina (UA), two (0.2%) with atypical manifestations of ACS and 26 (3%) with non-cardiac chest pain. During hospitalization, 87.9% of patients were given a beta-blocker, 95.9% acetylsalicylic acid, 89.9% anti-thrombin therapy, 86.2% intravenous nitroglycerin, 6.4% glycoprotein (GP) IIb/IIIa receptor inhibitor, 35.9% clopidogrel, 77.9% angiotensin-converting enzyme inhibitor, and 70,9% statin drugs. Coronary arteriography was performed in 72 patients (92.3%) with STEMI, and in 452 (59.8%) with non-STEMI ACS (p< 0.0001). Myocardial revascularization (MR) surgery was indicated for 12.9% and percutaneous coronary intervention for 26.6%. In-hospital mortality was 4.8%, and no difference was recorded between the proportion of deaths among patients with STEMI and non-STEMI ACS (6.4% versus 4.8%; p = 0.578). CONCLUSION: In this registry, we provide a description of ACS patient, which allows the evaluation of the demographic characteristics, medical treatment prescribed, and in-hospital mortality. A greater awareness of our reality may help the medical community to adhere more strictly to the procedures set by guidelines.
Databáze: Directory of Open Access Journals